|
 The partnership covers Brazil, Mexico, Indonesia, Philippines as
well as several countries in Africa and eastern Europe, among
others, Merck said in a statement on Tuesday.
The deal could add up to 20 new drugs to Merck's current portfolio
and first product launches are expected in 2016, it added.
Last year, emerging markets accounted for close to 1.8 billion euros
($2.3 billion) of total sales of 6 billion euros at Merck's
prescription drugs unit Merck Serono.
Lupin and Merck agreed not to disclose financial terms.
(Reporting by Ludwig Burger; Editing by Harro ten Wolde)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
[to top of second column] |
|
